# Royal (Wuxi) Bio-pharmaceutical Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/royal-wuxi-bio-pharmaceutical-co

- Industry: Biotechnology
- Headquarters: Wuxi, China
- Website: www.rbpc.com.cn
- Latest round: Series A (Jun 14, 2012)
- Investors on record: 1

## About

Based in Wuxi, China and established 2002, Royal (Wuxi) Bio-pharmaceutical Co., Ltd is a biopharmaceutical company that focuses on the development, manufacture and marketing of medicines cover treatment, precautionary and biological reagent area. In September 2021, the company completed strategic investment from Jun Yuan Capital. At present, the company covers an area of more than 100000 square meters, and the total investment in phase I is 25 million dollars.

The existing scientific research personnel account for 70% of the company's employees. The company has developed the freeze dried meningococcal conjugate vaccine of group A and group C for children from 6 months to 2 years old.

## Funding rounds

- Series A, Jun 14, 2012 — Detong Capital

## Investors

- Detong Capital (https://capitalatlas.ai/funds/detong-capital) — Series A